Discover how a new method for measuring iron flux helps scientists to rapidly identify high-quality cells for use in ...

Researchers have developed a new method for monitoring iron flux - the movement and rate at which cells take in, store, use ...

Company to Host Conference Call Today, March 30, at 4:30pm ETBOCA RATON, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company ...

Physicians and scientists from Longevity Medical Institute® have published new peer-reviewed research examining the safety of allogeneic mesenchymal stem cell therapies across a broad range of human ...

LOS CABOS, BAJA CALIFORNIA SUR, Mexico, March 17, 2026 /PRNewswire/ -- Physicians and scientists from Longevity Medical Institute(R) have published new peer-reviewed research examining the safety of ...

Q4 2025 Earnings Call March 30, 2026 4:30 PM EDTCompany ParticipantsDaniel Carlson - Head of Investor RelationsDavid Moss ...

Realizing the benefits of regenerative medicine will require a structural shift toward earlier detection and therapeutic intervention.

Mesoblast (ASX:MSB) founder and CEO Prof Silviu Itescu has a markedly more relaxed demeanor than in the past, when investors ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host its inaugural R&D Day on Wednesday, April 8, 2026 in New York City. The ...

USANewsGroup.com News Commentary -- The global cell therapy market is projected to surpass $8.2 billion in 2026, driven by a wave of clinical breakthroughs and manufacturing milestones reshaping ...